Asparagine-specific Enzyme [EPC]

Asparagine-specific Enzyme [EPC] was reported 13482 times

Drugs of the Asparagine-specific Enzyme [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTITHROMBIN III 13 0.8125
1 HUMAN BOCAVIRUS INFECTION 132 0.6984
2 CEREBRAL CANDIDIASIS 10 0.6667
3 LYMPHOID TISSUE HYPOPLASIA 78 0.5098
4 THYMUS HYPOPLASIA 84 0.4828
5 PERINEAL NECROSIS 19 0.4634
6 ENZYME ACTIVITY DECREASED 8 0.3636
7 CYSTITIS BACTERIAL 106 0.3136
8 HYPOFIBRINOGENAEMIA 305 0.3075
9 NOROVIRUS TEST POSITIVE 99 0.3046
10 MYCOBACTERIUM CHELONAE INFECTION 180 0.2436
11 ANTITHROMBIN III DECREASED 65 0.2381
12 ANTITHROMBIN III DEFICIENCY 19 0.2135
13 ABSCESS BACTERIAL 73 0.2011
14 SECONDARY IMMUNODEFICIENCY 235 0.1934
15 ACRAL LENTIGINOUS MELANOMA 8 0.1905
16 PICORNAVIRUS INFECTION 8 0.1860
17 FIBRINOUS BRONCHITIS 14 0.1842
18 STOMATOCOCCAL INFECTION 20 0.1613
19 FEBRILE BONE MARROW APLASIA 684 0.1608
20 MULTIPLE LENTIGINES SYNDROME 6 0.1579
21 LEWIS-SUMNER SYNDROME 8 0.1509
22 CORONA VIRUS INFECTION 64 0.1488
23 PERIORBITAL INFECTION 11 0.1358
24 BACILLUS TEST POSITIVE 13 0.1313
25 PSEUDOMONAL SEPSIS 220 0.1255
26 ANORECTAL CELLULITIS 7 0.1148
27 BACILLUS BACTERAEMIA 11 0.1009
28 CHEMOTHERAPEUTIC DRUG LEVEL INCREASED 17 0.0960
29 PERINEAL INFECTION 19 0.0960
30 PARAINFLUENZAE VIRUS INFECTION 139 0.0913
31 DISSEMINATED ASPERGILLOSIS 42 0.0890
32 OVERGROWTH FUNGAL 9 0.0874
33 ENTEROBACTER INFECTION 143 0.0850
34 DISSEMINATED TRICHOSPORONOSIS 6 0.0833
35 SUPERIOR SAGITTAL SINUS THROMBOSIS 66 0.0826
36 BLOOD FIBRINOGEN DECREASED 93 0.0814
37 HYPERTRIGLYCERIDAEMIA 464 0.0792
38 BACTEROIDES TEST POSITIVE 5 0.0758
39 HUMAN HERPESVIRUS 6 INFECTION 143 0.0756
40 PSEUDOHYPONATRAEMIA 10 0.0730
41 GALLBLADDER OEDEMA 21 0.0717
42 RENAL REPLACEMENT THERAPY 9 0.0703
43 ABSCESS FUNGAL 12 0.0686
44 PARAINFLUENZA VIRUS INFECTION 7 0.0680
45 ENCEPHALITIS FUNGAL 6 0.0667
46 DIFFUSE ALVEOLAR DAMAGE 75 0.0652
47 ESCHERICHIA PYELONEPHRITIS 16 0.0618
48 PYOMYOSITIS 18 0.0608
49 JAUNDICE HEPATOCELLULAR 6 0.0606
50 CONGENITAL APLASIA 18 0.0579
51 ENTEROVIRUS TEST POSITIVE 10 0.0575
52 VIRAEMIA 79 0.0570
53 ENTEROCOCCUS TEST POSITIVE 35 0.0540
54 RESPIRATORY MONILIASIS 14 0.0522
55 HUMAN METAPNEUMOVIRUS TEST POSITIVE 6 0.0508
56 PNEUMATOSIS INTESTINALIS 142 0.0497
57 CRYPTOCOCCAL FUNGAEMIA 7 0.0490
58 RHINOVIRUS INFECTION 189 0.0485
59 LENTIGO 24 0.0484
60 CYTOMEGALOVIRUS CHORIORETINITIS 92 0.0471
61 MUCOSAL INFECTION 11 0.0470
62 PSEUDOMONAS TEST POSITIVE 38 0.0464
63 HUMAN RHINOVIRUS TEST POSITIVE 17 0.0456
64 PROTHROMBIN LEVEL ABNORMAL 7 0.0455
65 CHOLANGITIS INFECTIVE 12 0.0451
66 ENTEROBACTER TEST POSITIVE 11 0.0447
67 MUCOCUTANEOUS ULCERATION 10 0.0441
68 LEUKAEMIC INFILTRATION 6 0.0429
69 CEREBRAL VENOUS SINUS THROMBOSIS 36 0.0426
70 INFECTIVE MYOSITIS 7 0.0419
71 ENCOPRESIS 8 0.0412
72 RHINOCEREBRAL MUCORMYCOSIS 14 0.0403
73 ECTHYMA 16 0.0399
74 GASTROENTERITIS NOROVIRUS 52 0.0391
75 CANDIDA TEST POSITIVE 16 0.0383
76 BLOOD CULTURE POSITIVE 114 0.0380
77 PANCREATITIS NECROTISING 87 0.0378
78 CAECITIS 17 0.0378
79 ESCHERICHIA TEST POSITIVE 45 0.0376
80 HYPERBILIRUBINAEMIA 386 0.0372
81 CEREBRAL VENOUS THROMBOSIS 66 0.0363
82 PSEUDOMONAL BACTERAEMIA 31 0.0363
83 FUSARIUM INFECTION 25 0.0357
84 BLOOD LACTIC ACID DECREASED 6 0.0349
85 TRICHOSPORON INFECTION 14 0.0346
86 ZYGOMYCOSIS 16 0.0342
87 CYTOMEGALOVIRUS HEPATITIS 12 0.0339
88 ENTEROBACTER BACTERAEMIA 10 0.0330
89 ANORECTAL INFECTION 8 0.0317
90 ESCHERICHIA BACTERAEMIA 73 0.0310
91 VENOOCCLUSIVE LIVER DISEASE 147 0.0297
92 PANCREATIC PSEUDOCYST 23 0.0296
93 GRAM STAIN POSITIVE 6 0.0291
94 BACILLUS INFECTION 18 0.0285
95 BRONCHOPULMONARY ASPERGILLOSIS 221 0.0285
96 TRANSVERSE SINUS THROMBOSIS 15 0.0285
97 PULMONARY MUCORMYCOSIS 15 0.0284
98 MUCORMYCOSIS 73 0.0281
99 PANCREATITIS HAEMORRHAGIC 13 0.0280
100 ASPERGILLUS INFECTION 179 0.0272
101 ESCHERICHIA SEPSIS 79 0.0272
102 SKIN CANDIDA 14 0.0268
103 ENTEROVIRUS INFECTION 23 0.0266
104 CLOSTRIDIUM DIFFICILE COLITIS 277 0.0261
105 OESOPHAGEAL CANDIDIASIS 104 0.0261
106 FEBRILE NEUTROPENIA 1709 0.0257
107 INTRACARDIAC THROMBUS 79 0.0257
108 SCEDOSPORIUM INFECTION 18 0.0255
109 VENOUS THROMBOSIS 100 0.0255
110 CYTOMEGALOVIRUS VIRAEMIA 110 0.0247
111 VENOOCCLUSIVE DISEASE 60 0.0239
112 CAVERNOUS SINUS THROMBOSIS 6 0.0236
113 DEVICE RELATED THROMBOSIS 23 0.0233
114 INTRACRANIAL VENOUS SINUS THROMBOSIS 25 0.0233
115 CARDIAC VENTRICULAR THROMBOSIS 30 0.0232
116 NEUTROPENIC COLITIS 48 0.0232
117 LOWER RESPIRATORY TRACT INFECTION FUNGAL 9 0.0231
118 KLEBSIELLA TEST POSITIVE 15 0.0230
119 POTENTIATING DRUG INTERACTION 77 0.0229
120 ENTEROCOLITIS INFECTIOUS 21 0.0228
121 STEROID DIABETES 34 0.0227
122 ENTERITIS 144 0.0225
123 HERPES ZOSTER MENINGOENCEPHALITIS 8 0.0222
124 APLASIA 43 0.0219
125 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 20 0.0216
126 MIXED ANXIETY AND DEPRESSIVE DISORDER 8 0.0216
127 LIVER TENDERNESS 6 0.0214
128 ANISOCORIA 8 0.0212
129 CLOSTRIDIUM TEST POSITIVE 46 0.0208
130 STEATOHEPATITIS 11 0.0205
131 FUNGAEMIA 32 0.0203
132 SINUSITIS FUNGAL 16 0.0200
133 INTUSSUSCEPTION 19 0.0199
134 VASCULAR ACCESS COMPLICATION 16 0.0198
135 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 51 0.0197
136 TRACHEITIS 15 0.0197
137 SYSTEMIC CANDIDA 49 0.0195
138 STAPHYLOCOCCUS TEST POSITIVE 41 0.0194
139 STAPHYLOCOCCAL SEPSIS 95 0.0192
140 CEREBRAL THROMBOSIS 54 0.0191
141 OTITIS MEDIA ACUTE 14 0.0190
142 CANDIDA SEPSIS 17 0.0190
143 RESPIRATORY TRACT INFECTION FUNGAL 10 0.0189
144 BRAIN MIDLINE SHIFT 10 0.0189
145 BACTERIAL INFECTION 353 0.0189
146 AXILLARY VEIN THROMBOSIS 7 0.0189
147 ANAL INFLAMMATION 12 0.0188
148 PNEUMONIA NECROTISING 12 0.0185
149 JUGULAR VEIN THROMBOSIS 33 0.0185
150 VULVITIS 6 0.0183
151 BONE MARROW INFILTRATION 7 0.0181
152 METASTASES TO PANCREAS 8 0.0181
153 PERIRECTAL ABSCESS 20 0.0180
154 HYPERAMMONAEMIA 87 0.0174
155 PANCREATIC NECROSIS 6 0.0173
156 UREAPLASMA INFECTION 7 0.0172
157 STENOTROPHOMONAS INFECTION 23 0.0169
158 LEUKOENCEPHALOPATHY 63 0.0169
159 DRUG CLEARANCE DECREASED 22 0.0168
160 GASTROINTESTINAL WALL THICKENING 25 0.0167
161 HYPOALBUMINAEMIA 127 0.0163
162 OEDEMATOUS PANCREATITIS 9 0.0160
163 HEPATOBILIARY DISEASE 10 0.0160
164 ANAL ULCER 13 0.0159
165 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 151 0.0158
166 SPLENIC VEIN THROMBOSIS 8 0.0158
167 BACTERIAL TRANSLOCATION 5 0.0158
168 PNEUMONIA FUNGAL 62 0.0157
169 CANDIDA PNEUMONIA 5 0.0155
170 SYSTEMIC MYCOSIS 18 0.0154
171 CENTRAL NERVOUS SYSTEM LEUKAEMIA 6 0.0153
172 CEREBRAL ASPERGILLOSIS 9 0.0146
173 MINIMAL RESIDUAL DISEASE 7 0.0145
174 LIPASE INCREASED 111 0.0145
175 NEUTRALISING ANTIBODIES POSITIVE 6 0.0144
176 STAPHYLOCOCCAL BACTERAEMIA 61 0.0140
177 STREPTOCOCCAL BACTERAEMIA 15 0.0138
178 CEREBRAL MASS EFFECT 5 0.0138
179 MUCOSAL INFLAMMATION 357 0.0136
180 CHRONIC HEPATITIS 11 0.0136
181 PERIPHERAL MOTOR NEUROPATHY 19 0.0136
182 POSTURING 7 0.0135
183 PNEUMATOSIS 6 0.0135
184 SOFT TISSUE NECROSIS 9 0.0131
185 B PRECURSOR TYPE ACUTE LEUKAEMIA 5 0.0129
186 HAEMORRHAGIC INFARCTION 7 0.0128
187 ABDOMINAL COMPARTMENT SYNDROME 8 0.0126
188 PLATELET TRANSFUSION 16 0.0124
189 HEPATOCELLULAR INJURY 174 0.0123
190 HERPES SIMPLEX 79 0.0121
191 GALLBLADDER ENLARGEMENT 13 0.0121
192 CELLULITIS ORBITAL 7 0.0120
193 HYPOGONADISM 12 0.0119
194 HISTIOCYTOSIS HAEMATOPHAGIC 35 0.0118
195 CITROBACTER INFECTION 5 0.0117
196 CORONAVIRUS TEST POSITIVE 12 0.0117
197 KLEBSIELLA BACTERAEMIA 11 0.0116
198 POST LUMBAR PUNCTURE SYNDROME 12 0.0115
199 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 8 0.0114
200 BLOOD LACTIC ACID INCREASED 60 0.0114
201 CENTRAL NERVOUS SYSTEM INFECTION 13 0.0113
202 GASTROINTESTINAL NECROSIS 33 0.0113
203 COAGULOPATHY 188 0.0113
204 BACTERAEMIA 133 0.0112
205 PERIORBITAL CELLULITIS 6 0.0112
206 PANCREATITIS ACUTE 245 0.0109
207 FUNGAL SEPSIS 9 0.0108
208 SEPTIC EMBOLUS 9 0.0108
209 INTRACRANIAL HYPOTENSION 7 0.0107
210 KLEBSIELLA SEPSIS 12 0.0106
211 LEUKAEMIA RECURRENT 18 0.0106
212 SUBCLAVIAN VEIN THROMBOSIS 12 0.0105
213 ANGIOCENTRIC LYMPHOMA 5 0.0102
214 RESPIRATORY TRACT HAEMORRHAGE 6 0.0101
215 PULMONARY HAEMORRHAGE 78 0.0100
216 SCROTAL OEDEMA 7 0.0098
217 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 8 0.0098
218 GASTROINTESTINAL ULCER HAEMORRHAGE 11 0.0098
219 VASOGENIC CEREBRAL OEDEMA 7 0.0097
220 PULSE ABSENT 46 0.0097
221 PANCREATITIS 507 0.0096
222 B-CELL TYPE ACUTE LEUKAEMIA 7 0.0095
223 RECTAL FISSURE 6 0.0095
224 BACTERIAL SEPSIS 31 0.0095
225 BLOOD IMMUNOGLOBULIN A DECREASED 6 0.0092
226 HEPATOMEGALY 90 0.0091
227 COAGULATION TEST ABNORMAL 7 0.0091
228 PACKED RED BLOOD CELL TRANSFUSION 12 0.0091
229 CHOLESTASIS 173 0.0090
230 BILIRUBIN CONJUGATED INCREASED 21 0.0090
231 HEPATIC STEATOSIS 166 0.0089
232 ESCHERICHIA INFECTION 73 0.0089
233 OESOPHAGITIS ULCERATIVE 6 0.0088
234 SOFT TISSUE INFECTION 16 0.0087
235 ATRIAL THROMBOSIS 18 0.0087
236 ENTEROCOCCAL SEPSIS 7 0.0086
237 AMMONIA INCREASED 44 0.0086
238 STREPTOCOCCAL SEPSIS 10 0.0084
239 CAMPYLOBACTER INFECTION 7 0.0084
240 AMYLASE INCREASED 31 0.0084
241 DERMO-HYPODERMITIS 5 0.0084
242 HYPERPHOSPHATAEMIA 18 0.0084
243 HEPATOTOXICITY 186 0.0083
244 SEPTIC SHOCK 357 0.0082
245 VIRAL INFECTION 273 0.0082
246 PNEUMONIA VIRAL 26 0.0081
247 ENTEROCOLITIS 47 0.0081
248 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 41 0.0081
249 TREATMENT DELAYED 14 0.0081
250 PUPIL FIXED 14 0.0081
251 HEART SOUNDS ABNORMAL 6 0.0080
252 BLOOD BILIRUBIN INCREASED 215 0.0080
253 PSEUDOMONAS INFECTION 68 0.0079
254 QUADRIPARESIS 13 0.0078
255 VOCAL CORD PARALYSIS 14 0.0078
256 OESOPHAGEAL STENOSIS 22 0.0077
257 KLEBSIELLA INFECTION 39 0.0077
258 TONIC CLONIC MOVEMENTS 10 0.0077
259 CYTOGENETIC ANALYSIS ABNORMAL 8 0.0076
260 HYPERLIPIDAEMIA 91 0.0076
261 PRODUCT CONTAMINATION MICROBIAL 9 0.0075
262 INTERVERTEBRAL DISCITIS 14 0.0074
263 ENTEROCOCCAL INFECTION 35 0.0072
264 BONE MARROW FAILURE 146 0.0072
265 CONTINUOUS HAEMODIAFILTRATION 7 0.0072
266 HEPATITIS CHOLESTATIC 43 0.0071
267 ISCHAEMIC CEREBRAL INFARCTION 8 0.0069
268 OPTIC NERVE DISORDER 11 0.0069
269 MYELOSUPPRESSION 246 0.0068
270 PROCALCITONIN INCREASED 8 0.0068
271 MULTIPLE ORGAN DYSFUNCTION SYNDROME 192 0.0068
272 ACUTE LYMPHOCYTIC LEUKAEMIA 19 0.0067
273 VARICELLA 16 0.0067
274 BRAIN HERNIATION 20 0.0067
275 DISSEMINATED INTRAVASCULAR COAGULATION 94 0.0067
276 GLYCOSURIA 9 0.0067
277 ORAL HERPES 130 0.0067
278 CATARRH 6 0.0066
279 HYPERTRANSAMINASAEMIA 46 0.0066
280 URETERIC OBSTRUCTION 9 0.0066
281 GAMMA-GLUTAMYLTRANSFERASE INCREASED 146 0.0066
282 NEUROTOXICITY 115 0.0066
283 IRON OVERLOAD 7 0.0065
284 NEUROLOGICAL DECOMPENSATION 15 0.0065
285 TUMOUR LYSIS SYNDROME 57 0.0065
286 KIDNEY ENLARGEMENT 7 0.0064
287 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 48 0.0064
288 HYPERGLYCAEMIA 233 0.0064
289 ANAPHYLACTIC REACTION 352 0.0064
290 BLOOD FIBRINOGEN INCREASED 5 0.0063
291 TACHYPNOEA 86 0.0063
292 MENINGITIS BACTERIAL 9 0.0063
293 HYPOCOAGULABLE STATE 6 0.0062
294 BRAIN DEATH 19 0.0061
295 HYPERAEMIA 12 0.0061
296 CEREBRAL ISCHAEMIA 31 0.0060
297 CATHETER SITE HAEMORRHAGE 15 0.0060
298 PNEUMONIA KLEBSIELLA 11 0.0060
299 PULSELESS ELECTRICAL ACTIVITY 25 0.0060
300 DEVICE RELATED INFECTION 92 0.0060
301 HEPATIC CYTOLYSIS 75 0.0059
302 FUNGAL INFECTION 195 0.0058
303 BACTERIAL TEST POSITIVE 13 0.0058
304 RESPIRATORY DISTRESS 160 0.0058
305 PHARYNGEAL INFLAMMATION 7 0.0058
306 BREAKTHROUGH PAIN 13 0.0056
307 ADENOVIRUS INFECTION 16 0.0055
308 CANDIDA INFECTION 93 0.0055
309 COLITIS 208 0.0055
310 PANCYTOPENIA 305 0.0055
311 HEPATOSPLENOMEGALY 14 0.0054
312 CORONAVIRUS INFECTION 36 0.0054
313 OCULAR TOXICITY 6 0.0054
314 CEREBROSPINAL FLUID LEAKAGE 10 0.0054
315 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 6 0.0054
316 ACIDOSIS 41 0.0054
317 SEPSIS 596 0.0053
318 HEPATORENAL SYNDROME 9 0.0053
319 ASCITES 156 0.0053
320 BLOOD PRESSURE IMMEASURABLE 8 0.0052
321 RESPIRATORY SYNCYTIAL VIRUS INFECTION 45 0.0052
322 SPLENIC INFARCTION 9 0.0052
323 PERIPHERAL SENSORY NEUROPATHY 30 0.0051
324 FEBRILE INFECTION 6 0.0051
325 MALNUTRITION 57 0.0051
326 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 9 0.0051
327 INTRA-ABDOMINAL FLUID COLLECTION 9 0.0050
328 LUNG CONSOLIDATION 14 0.0050
329 PNEUMONIA LEGIONELLA 8 0.0050
330 PNEUMOMEDIASTINUM 9 0.0050
331 HEPATIC FIBROSIS 17 0.0049
332 EMBOLISM VENOUS 15 0.0049
333 ILEUS PARALYTIC 22 0.0049
334 ANGIONEUROTIC OEDEMA 13 0.0049
335 CAPILLARY LEAK SYNDROME 10 0.0048
336 HEPATIC FAILURE 145 0.0048
337 SUBILEUS 10 0.0048
338 ENCEPHALITIS 33 0.0048
339 WHITE MATTER LESION 6 0.0047
340 HYPOPROTEINAEMIA 9 0.0047
341 PANCREATIC CYST 9 0.0047
342 ESCHERICHIA URINARY TRACT INFECTION 20 0.0047
343 NEUTROPENIA 638 0.0047
344 ALANINE AMINOTRANSFERASE INCREASED 288 0.0047
345 CEREBRAL ARTERY OCCLUSION 5 0.0047
346 ATELECTASIS 45 0.0047
347 MENINGITIS 31 0.0046
348 EMBOLISM 38 0.0046
349 CYTOPENIA 56 0.0046
350 LYMPHOPENIA 64 0.0045
351 PROTHROMBIN TIME PROLONGED 27 0.0045
352 DEVICE RELATED SEPSIS 9 0.0045
353 CYSTITIS HAEMORRHAGIC 18 0.0045
354 CHOLECYSTITIS 53 0.0044
355 HYPOGAMMAGLOBULINAEMIA 29 0.0044
356 QUADRIPLEGIA 9 0.0044
357 VARICELLA ZOSTER VIRUS INFECTION 9 0.0043
358 PNEUMOPERITONEUM 8 0.0043
359 NECROSIS 24 0.0043
360 ABDOMINAL INFECTION 11 0.0043
361 H1N1 INFLUENZA 6 0.0043
362 BRONCHIAL OBSTRUCTION 6 0.0043
363 LIP OEDEMA 18 0.0042
364 APLASTIC ANAEMIA 22 0.0042
365 INTRA-ABDOMINAL HAEMORRHAGE 10 0.0042
366 ILEUS 52 0.0042
367 TACHYCARDIA 367 0.0041
368 GAZE PALSY 7 0.0041
369 NON-CARDIAC CHEST PAIN 13 0.0041
370 CHOLECYSTITIS ACUTE 23 0.0041
371 DRUG-INDUCED LIVER INJURY 127 0.0040
372 BRAIN OEDEMA 51 0.0040
373 SKIN STRIAE 6 0.0040
374 ENCEPHALOPATHY 98 0.0040
375 RENAL COLIC 9 0.0040
376 HYPOVOLAEMIC SHOCK 19 0.0040
377 MITRAL VALVE DISEASE 7 0.0040
378 BRAIN ABSCESS 10 0.0039
379 NEUTROPHIL COUNT DECREASED 161 0.0039
380 FIBRIN D DIMER INCREASED 14 0.0039
381 THROMBOCYTOPENIA 437 0.0039
382 CALCULUS URINARY 6 0.0039
383 HYPOXIA 137 0.0039
384 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
385 PARTIAL SEIZURES 20 0.0038
386 PULMONARY INFARCTION 9 0.0038
387 HAEMODYNAMIC INSTABILITY 29 0.0038
388 UNRESPONSIVE TO STIMULI 97 0.0038
389 STRABISMUS 11 0.0037
390 APNOEA 29 0.0037
391 MYELOPATHY 7 0.0037
392 METABOLIC ENCEPHALOPATHY 11 0.0037
393 SINUS TACHYCARDIA 52 0.0037
394 DRUG SPECIFIC ANTIBODY 5 0.0036
395 BLOOD IMMUNOGLOBULIN G DECREASED 9 0.0036
396 PLEURITIC PAIN 10 0.0036
397 VENA CAVA THROMBOSIS 6 0.0036
398 URINARY TRACT INFECTION BACTERIAL 9 0.0036
399 CULTURE URINE POSITIVE 5 0.0036
400 BK VIRUS INFECTION 12 0.0036
401 POLYDIPSIA 14 0.0035
402 COMPUTERISED TOMOGRAM ABNORMAL 8 0.0035
403 EPSTEIN-BARR VIRUS INFECTION 22 0.0035
404 FUNGAL SKIN INFECTION 14 0.0035
405 LUNG OPACITY 9 0.0034
406 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 13 0.0034
407 STRIDOR 10 0.0034
408 MENTAL STATUS CHANGES 94 0.0034
409 TRANSAMINASES INCREASED 75 0.0034
410 SHOCK 77 0.0033
411 GRAFT VERSUS HOST DISEASE 24 0.0033
412 CELLULITIS 168 0.0033
413 HAEMATOLOGICAL INFECTION 8 0.0033
414 DRUG LEVEL BELOW THERAPEUTIC 18 0.0033
415 CLOSTRIDIUM DIFFICILE INFECTION 71 0.0032
416 HYPOPHAGIA 83 0.0032
417 GRANULOCYTE COUNT DECREASED 6 0.0032
418 HAEMORRHAGE INTRACRANIAL 48 0.0032
419 URINE OUTPUT DECREASED 28 0.0032
420 SHOCK HAEMORRHAGIC 26 0.0032
421 BLOOD BICARBONATE DECREASED 6 0.0032
422 ACUTE HEPATIC FAILURE 43 0.0031
423 CHOLESTATIC LIVER INJURY 7 0.0031
424 HEMIPARESIS 53 0.0031
425 DISTRIBUTIVE SHOCK 7 0.0031
426 EYE MOVEMENT DISORDER 21 0.0031
427 STREPTOCOCCAL INFECTION 17 0.0031
428 ACUTE RESPIRATORY DISTRESS SYNDROME 54 0.0031
429 INTRACRANIAL PRESSURE INCREASED 17 0.0030
430 FACIAL PARALYSIS 26 0.0030
431 SERUM FERRITIN INCREASED 16 0.0030
432 CELL DEATH 6 0.0030
433 BLOOD ALBUMIN DECREASED 24 0.0030
434 HYPERNATRAEMIA 15 0.0030
435 VENTRICULAR ARRHYTHMIA 11 0.0030
436 RESPIRATORY TRACT INFECTION VIRAL 7 0.0030
437 HYPERSENSITIVITY 555 0.0030
438 BONE MARROW DISORDER 9 0.0030
439 STOMATITIS 179 0.0029
440 BLOOD TRIGLYCERIDES INCREASED 52 0.0029
441 ASPARTATE AMINOTRANSFERASE INCREASED 156 0.0029
442 HYDROCEPHALUS 16 0.0029
443 SUBDURAL HAEMORRHAGE 8 0.0029
444 RESPIRATORY FAILURE 213 0.0029
445 BRAIN NATRIURETIC PEPTIDE INCREASED 9 0.0029
446 PORTAL HYPERTENSION 9 0.0029
447 INTESTINAL ISCHAEMIA 16 0.0029
448 VASCULAR DEVICE INFECTION 13 0.0029
449 PROCTITIS 8 0.0029
450 PLEURAL EFFUSION 173 0.0028
451 NECROTISING FASCIITIS 10 0.0028
452 HYPERVOLAEMIA 14 0.0028
453 FLUID OVERLOAD 41 0.0028
454 PROCTALGIA 18 0.0028
455 PALLOR 76 0.0028
456 HERPES VIRUS INFECTION 16 0.0028
457 CEREBRAL ATROPHY 11 0.0028
458 OLIGURIA 17 0.0027
459 THROMBOCYTOSIS 10 0.0027
460 HYPERCHOLESTEROLAEMIA 26 0.0027
461 PNEUMOCYSTIS JIROVECII PNEUMONIA 27 0.0027
462 PETECHIAE 28 0.0027
463 HYPERURICAEMIA 11 0.0027
464 ENDOPHTHALMITIS 16 0.0027
465 LEUKOPENIA 133 0.0027
466 HYPERCAPNIA 8 0.0027
467 PROTEIN TOTAL DECREASED 10 0.0027
468 PERONEAL NERVE PALSY 15 0.0026
469 ADRENAL INSUFFICIENCY 32 0.0026
470 AREFLEXIA 7 0.0026
471 GASTROINTESTINAL INJURY 7 0.0026
472 ORAL DISORDER 19 0.0026
473 METABOLIC DISORDER 15 0.0026
474 ELECTROLYTE IMBALANCE 30 0.0026
475 CYSTITIS 82 0.0026
476 HEPATIC ENCEPHALOPATHY 24 0.0026
477 TOXIC ENCEPHALOPATHY 13 0.0026
478 DIALYSIS 36 0.0025
479 ELECTROENCEPHALOGRAM ABNORMAL 8 0.0025
480 CACHEXIA 13 0.0025
481 LUNG INFECTION 39 0.0025
482 POLYNEUROPATHY 30 0.0025
483 ANAL HAEMORRHAGE 7 0.0025
484 TYPE 1 DIABETES MELLITUS 15 0.0025
485 STAPHYLOCOCCAL INFECTION 82 0.0025
486 FOETAL GROWTH RESTRICTION 15 0.0025
487 DRUG SPECIFIC ANTIBODY PRESENT 16 0.0025
488 INFUSION RELATED REACTION 162 0.0024
489 OSTEONECROSIS 80 0.0024
490 GENERALISED OEDEMA 30 0.0024
491 HYPOTENSION 485 0.0024
492 GENERALISED TONIC-CLONIC SEIZURE 40 0.0024
493 INTRAVENTRICULAR HAEMORRHAGE 6 0.0024
494 STEM CELL TRANSPLANT 6 0.0024
495 CEREBRAL HAEMATOMA 8 0.0024
496 NEUTROPENIC SEPSIS 17 0.0024
497 WOUND DEHISCENCE 8 0.0024
498 NEOPLASM RECURRENCE 8 0.0024
499 APPENDICITIS 22 0.0024
500 PYREXIA 806 0.0023
501 HYPONATRAEMIA 131 0.0023
502 HEPATIC LESION 10 0.0023
503 OCULAR ICTERUS 10 0.0023
504 SUBDURAL HAEMATOMA 33 0.0023
505 HEPATITIS TOXIC 6 0.0023
506 PERICARDIAL EFFUSION 53 0.0023
507 CEREBRAL HAEMORRHAGE 82 0.0023
508 HEMIPLEGIA 19 0.0023
509 ABDOMINAL PAIN 530 0.0023
510 HAEMODIALYSIS 19 0.0023
511 FACIAL PARESIS 8 0.0023
512 HYPOKALAEMIA 104 0.0023
513 CYTOKINE RELEASE SYNDROME 45 0.0022
514 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 23 0.0022
515 ANAL FISSURE 12 0.0022
516 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 38 0.0022
517 ANURIA 19 0.0022
518 ODYNOPHAGIA 13 0.0022
519 DYSLIPIDAEMIA 11 0.0022
520 PLATELET COUNT DECREASED 230 0.0022
521 BODY TEMPERATURE INCREASED 44 0.0022
522 LUNG INFILTRATION 19 0.0021
523 CHRONIC SINUSITIS 8 0.0021
524 PERIORBITAL OEDEMA 11 0.0021
525 PULMONARY MASS 31 0.0021
526 GUILLAIN-BARRE SYNDROME 10 0.0021
527 CARDIO-RESPIRATORY ARREST 86 0.0021
528 HYPOVOLAEMIA 12 0.0020
529 PARONYCHIA 9 0.0020
530 LARGE INTESTINE PERFORATION 14 0.0020
531 ABDOMINAL TENDERNESS 10 0.0020
532 JAUNDICE CHOLESTATIC 7 0.0020
533 LACTIC ACIDOSIS 64 0.0020
534 CONJUNCTIVAL HYPERAEMIA 7 0.0020
535 CHEST X-RAY ABNORMAL 6 0.0020
536 ANAPHYLACTIC SHOCK 50 0.0019
537 AGRANULOCYTOSIS 36 0.0019
538 CYANOSIS 30 0.0019
539 SEIZURE 219 0.0019
540 HYPOPHOSPHATAEMIA 14 0.0019
541 LOW BIRTH WEIGHT BABY 15 0.0019
542 OXYGEN SATURATION DECREASED 106 0.0019
543 ORTHOPNOEA 6 0.0019
544 CARDIAC DYSFUNCTION 7 0.0019
545 POOR PERIPHERAL CIRCULATION 8 0.0019
546 LIVER INJURY 46 0.0019
547 ACUTE RESPIRATORY FAILURE 36 0.0019
548 PORTAL VEIN THROMBOSIS 6 0.0019
549 CATHETER SITE INFECTION 7 0.0018
550 HEPATITIS ACUTE 12 0.0018
551 BLOOD PHOSPHORUS INCREASED 5 0.0018
552 BRADYCARDIA 97 0.0018
553 OTITIS MEDIA 6 0.0018
554 ABDOMINAL ABSCESS 8 0.0018
555 FAECES HARD 7 0.0018
556 CARDIOPULMONARY FAILURE 7 0.0018
557 HEPATIC FUNCTION ABNORMAL 67 0.0018
558 RESPIRATORY ACIDOSIS 7 0.0018
559 CLOSTRIDIAL INFECTION 6 0.0018
560 MOUTH HAEMORRHAGE 13 0.0018
561 HYPOGLYCAEMIA 86 0.0018
562 EYELID PTOSIS 18 0.0018
563 SUBARACHNOID HAEMORRHAGE 18 0.0018
564 PHOTOPHOBIA 33 0.0018
565 ACUTE KIDNEY INJURY 267 0.0017
566 HYPOCALCAEMIA 33 0.0017
567 ANAEMIA 332 0.0017
568 PYELONEPHRITIS 15 0.0017
569 CAROTID ARTERY STENOSIS 6 0.0017
570 IMMUNOSUPPRESSION 15 0.0017
571 HYPOTHERMIA 17 0.0017
572 ORAL CANDIDIASIS 22 0.0017
573 CENTRAL VENOUS CATHETERISATION 5 0.0017
574 HAEMATEMESIS 42 0.0017
575 CEREBRAL INFARCTION 40 0.0016
576 CARDIAC ARREST 135 0.0016
577 DUODENITIS 5 0.0016
578 MYOPATHY 14 0.0016
579 BRONCHOSPASM 23 0.0016
580 NEPHROPATHY TOXIC 18 0.0016
581 BLOOD CREATININE DECREASED 5 0.0016
582 POLYURIA 13 0.0016
583 MOTOR DYSFUNCTION 16 0.0016
584 METABOLIC ACIDOSIS 50 0.0016
585 LIP SWELLING 52 0.0016
586 ENDOCARDITIS 8 0.0016
587 FACE OEDEMA 26 0.0015
588 FAILURE TO THRIVE 8 0.0015
589 LIVER FUNCTION TEST INCREASED 33 0.0015
590 TRANSFUSION 16 0.0015
591 PNEUMOTHORAX 24 0.0015
592 LEUKAEMIA 14 0.0015
593 NEUROPATHY PERIPHERAL 140 0.0015
594 EYELID OEDEMA 17 0.0015
595 WHITE BLOOD CELL COUNT DECREASED 156 0.0014
596 PATHOGEN RESISTANCE 13 0.0014
597 INTESTINAL PERFORATION 16 0.0014
598 ACUTE MYELOID LEUKAEMIA 22 0.0014
599 VOMITING 663 0.0014
600 DYSARTHRIA 53 0.0014
601 ABSCESS LIMB 6 0.0014
602 HYPOTONIA 14 0.0014
603 FLUID INTAKE REDUCED 7 0.0014
604 CYTOMEGALOVIRUS INFECTION 23 0.0014
605 SMALL INTESTINAL OBSTRUCTION 17 0.0014
606 BLOOD ALKALINE PHOSPHATASE INCREASED 34 0.0014
607 HAEMATOTOXICITY 13 0.0014
608 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
609 CARDIOTOXICITY 12 0.0013
610 ISCHAEMIC STROKE 24 0.0013
611 JAUNDICE 36 0.0013
612 MYOSITIS 12 0.0013
613 BRONCHIECTASIS 9 0.0013
614 INTERNATIONAL NORMALISED RATIO INCREASED 38 0.0013
615 GANGRENE 8 0.0013
616 SECOND PRIMARY MALIGNANCY 11 0.0013
617 NEURALGIA 32 0.0013
618 INFARCTION 9 0.0013
619 BLOOD UREA INCREASED 22 0.0013
620 ANGIOEDEMA 58 0.0013
621 PNEUMONIA BACTERIAL 12 0.0013
622 ANAL ABSCESS 7 0.0013
623 LARYNGEAL OEDEMA 8 0.0013
624 BRUXISM 7 0.0013
625 CIRCULATORY COLLAPSE 22 0.0013
626 INFUSION SITE EXTRAVASATION 8 0.0013
627 HAEMORRHAGIC STROKE 10 0.0013
628 DRUG LEVEL DECREASED 13 0.0013
629 BLOOD SODIUM DECREASED 24 0.0013
630 VENTRICULAR TACHYCARDIA 21 0.0013
631 METASTASIS 9 0.0013
632 DIABETIC KETOACIDOSIS 30 0.0012
633 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
634 CANDIDIASIS 5 0.0012
635 BLOOD CALCIUM DECREASED 14 0.0012
636 HAEMOGLOBIN DECREASED 127 0.0012
637 THROMBOTIC MICROANGIOPATHY 12 0.0012
638 NEUROLOGICAL SYMPTOM 7 0.0012
639 ANAPHYLACTOID REACTION 5 0.0012
640 MUCOUS STOOLS 6 0.0012
641 INFECTION 175 0.0012
642 RALES 7 0.0012
643 BRAIN INJURY 12 0.0012
644 HYPERTHERMIA 9 0.0012
645 DIARRHOEA HAEMORRHAGIC 11 0.0012
646 FLANK PAIN 11 0.0012
647 ECCHYMOSIS 8 0.0012
648 GASTROENTERITIS 17 0.0012
649 APHASIA 35 0.0012
650 DROOLING 8 0.0012
651 MULTI-ORGAN FAILURE 20 0.0012
652 SKIN NECROSIS 6 0.0012
653 PNEUMONIA 374 0.0012
654 THERAPY PARTIAL RESPONDER 18 0.0012
655 TONSILLITIS 6 0.0011
656 HEPATITIS 29 0.0011
657 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
658 PULMONARY EMBOLISM 107 0.0011
659 DEEP VEIN THROMBOSIS 73 0.0011
660 ORAL PAIN 25 0.0011
661 RHINITIS 9 0.0011
662 BLOOD PRESSURE DECREASED 74 0.0011
663 HYPERKALAEMIA 39 0.0011
664 SCREAMING 7 0.0011
665 URTICARIA 180 0.0011
666 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
667 DEHYDRATION 142 0.0011
668 GRANULOCYTOPENIA 6 0.0011
669 MYOCARDITIS 12 0.0010
670 HAEMOLYSIS 8 0.0010
671 CHILLS 121 0.0010
672 DRUG LEVEL INCREASED 17 0.0010
673 LETHARGY 59 0.0010
674 GASTROINTESTINAL INFLAMMATION 8 0.0010
675 SKIN LESION 28 0.0010
676 TORSADE DE POINTES 8 0.0010
677 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
678 CARDIOMYOPATHY 15 0.0010
679 BREATH SOUNDS ABNORMAL 5 0.0010
680 HEPATIC CIRRHOSIS 19 0.0010
681 PULMONARY OEDEMA 45 0.0010
682 SKIN INFECTION 11 0.0010
683 GRAND MAL CONVULSION 9 0.0010
684 STATUS EPILEPTICUS 11 0.0010
685 CHOLANGITIS 6 0.0010
686 ACUTE CORONARY SYNDROME 8 0.0010
687 LYMPHOCYTE COUNT DECREASED 17 0.0010
688 DEPRESSED LEVEL OF CONSCIOUSNESS 38 0.0010
689 SWELLING FACE 62 0.0010
690 BLINDNESS TRANSIENT 7 0.0009
691 CHOLELITHIASIS 31 0.0009
692 RETCHING 20 0.0009
693 THERAPY NON-RESPONDER 42 0.0009
694 RENAL FAILURE 124 0.0009
695 COVID-19 PNEUMONIA 11 0.0009
696 RESPIRATORY RATE INCREASED 8 0.0009
697 VENTRICULAR FIBRILLATION 10 0.0009
698 LIVER DISORDER 39 0.0009
699 RESPIRATION ABNORMAL 6 0.0009
700 PERITONITIS 18 0.0009
701 HAEMOPTYSIS 24 0.0009
702 PRODUCT USE IN UNAPPROVED INDICATION 212 0.0009
703 THROAT TIGHTNESS 23 0.0008
704 GASTROINTESTINAL HAEMORRHAGE 71 0.0008
705 THROMBOSIS 68 0.0008
706 EJECTION FRACTION DECREASED 13 0.0008
707 RESPIRATORY DISORDER 25 0.0008
708 OEDEMA 45 0.0008
709 EPISTAXIS 61 0.0008
710 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
711 HAEMATOMA 21 0.0008
712 RESPIRATORY TRACT INFECTION 21 0.0008
713 COUGH 225 0.0008
714 GASTRITIS 21 0.0008
715 TOXIC SKIN ERUPTION 8 0.0008
716 HEART RATE INCREASED 78 0.0008
717 MUSCULAR WEAKNESS 89 0.0008
718 NEUTROPHIL COUNT INCREASED 8 0.0008
719 UPPER RESPIRATORY TRACT INFECTION 36 0.0008
720 ANAL INCONTINENCE 7 0.0008
721 VENTRICULAR EXTRASYSTOLES 8 0.0008
722 GENERAL PHYSICAL HEALTH DETERIORATION 89 0.0008
723 HEPATIC ENZYME INCREASED 52 0.0008
724 HYPERTENSION 161 0.0008
725 MOUTH ULCERATION 16 0.0008
726 LIVER FUNCTION TEST ABNORMAL 22 0.0008
727 OROPHARYNGEAL PAIN 70 0.0008
728 DELIRIUM 26 0.0007
729 SENSORY LOSS 6 0.0007
730 TOXICITY TO VARIOUS AGENTS 124 0.0007
731 AGITATION 54 0.0007
732 DIABETES MELLITUS 56 0.0007
733 OESOPHAGITIS 8 0.0007
734 HYPERCALCAEMIA 9 0.0007
735 BLOOD CREATININE INCREASED 47 0.0007
736 VITREOUS FLOATERS 7 0.0007
737 HAEMATOCRIT DECREASED 14 0.0007
738 MYDRIASIS 9 0.0007
739 HAEMATURIA 24 0.0007
740 SALIVARY HYPERSECRETION 7 0.0007
741 SKIN HYPERPIGMENTATION 6 0.0007
742 CARDIOGENIC SHOCK 10 0.0007
743 HERPES ZOSTER 40 0.0007
744 MYELODYSPLASTIC SYNDROME 10 0.0007
745 DECREASED APPETITE 159 0.0007
746 GASTRIC ULCER 13 0.0007
747 INTERSTITIAL LUNG DISEASE 33 0.0007
748 IMMUNODEFICIENCY 10 0.0007
749 HAEMORRHAGE 70 0.0007
750 PNEUMONITIS 18 0.0007
751 ABDOMINAL DISTENSION 69 0.0007
752 C-REACTIVE PROTEIN INCREASED 24 0.0007
753 PERIPHERAL COLDNESS 9 0.0007
754 PHARYNGEAL OEDEMA 10 0.0006
755 FLUSHING 66 0.0006
756 NERVOUS SYSTEM DISORDER 20 0.0006
757 ASPIRATION 7 0.0006
758 NEOPLASM PROGRESSION 22 0.0006
759 PARALYSIS 9 0.0006
760 HYPOTHYROIDISM 20 0.0006
761 CHROMATURIA 14 0.0006
762 EAR PAIN 12 0.0006
763 ASPHYXIA 5 0.0006
764 CARDIAC FAILURE 49 0.0006
765 THERAPY CHANGE 6 0.0006
766 GASTRIC HAEMORRHAGE 7 0.0006
767 ERYTHEMA 125 0.0006
768 OSTEOMYELITIS 11 0.0006
769 RENAL INJURY 18 0.0006
770 SARS-COV-2 TEST POSITIVE 8 0.0006
771 SINUSITIS 62 0.0006
772 RHINORRHOEA 39 0.0006
773 VASCULITIS 7 0.0006
774 HEAD INJURY 19 0.0006
775 SYNCOPE 60 0.0006
776 MELAENA 13 0.0006
777 ATAXIA 7 0.0006
778 MYOCLONUS 7 0.0006
779 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
780 DRUG INTERACTION 92 0.0006
781 THROAT IRRITATION 26 0.0006
782 NAUSEA 457 0.0006
783 LUNG DISORDER 28 0.0006
784 INCONTINENCE 6 0.0006
785 DISEASE PROGRESSION 67 0.0006
786 DYSKINESIA 23 0.0006
787 PHARYNGITIS 7 0.0006
788 RECTAL HAEMORRHAGE 24 0.0006
789 HYPOKINESIA 8 0.0006
790 SKIN ULCER 14 0.0005
791 COVID-19 95 0.0005
792 CONSTIPATION 116 0.0005
793 PAIN IN JAW 15 0.0005
794 CRYING 19 0.0005
795 PAIN IN EXTREMITY 154 0.0005
796 DIZZINESS POSTURAL 5 0.0005
797 SPLENOMEGALY 6 0.0005
798 URINARY RETENTION 17 0.0005
799 WHEEZING 30 0.0005
800 GALLBLADDER DISORDER 9 0.0005
801 HYPOMAGNESAEMIA 7 0.0005
802 PRESYNCOPE 12 0.0005
803 OEDEMA PERIPHERAL 60 0.0005
804 EPILEPSY 15 0.0005
805 HAEMATOCHEZIA 27 0.0005
806 MEDICATION ERROR 27 0.0005
807 IRRITABILITY 29 0.0005
808 DERMATITIS ALLERGIC 6 0.0005
809 INCREASED APPETITE 9 0.0005
810 DRUG RESISTANCE 12 0.0005
811 FEELING COLD 13 0.0005
812 BLOOD POTASSIUM DECREASED 14 0.0005
813 DISEASE RECURRENCE 22 0.0005
814 BLOOD COUNT ABNORMAL 7 0.0005
815 CHOKING 9 0.0005
816 BONE PAIN 27 0.0005
817 RASH ERYTHEMATOUS 22 0.0005
818 ORTHOSTATIC HYPOTENSION 8 0.0005
819 CONFUSIONAL STATE 74 0.0005
820 IMMUNE SYSTEM DISORDER 6 0.0005
821 DYSPHAGIA 43 0.0005
822 DYSPNOEA EXERTIONAL 17 0.0005
823 GAIT INABILITY 15 0.0004
824 OFF LABEL USE 388 0.0004
825 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
826 LEUKOCYTOSIS 8 0.0004
827 TOOTHACHE 8 0.0004
828 ABSCESS 7 0.0004
829 RESPIRATORY ARREST 12 0.0004
830 ORAL DISCOMFORT 6 0.0004
831 HEADACHE 268 0.0004
832 HALLUCINATION, VISUAL 9 0.0004
833 CHEST PAIN 78 0.0004
834 ASTHENIA 158 0.0004
835 CHEST DISCOMFORT 43 0.0004
836 CONVULSION 24 0.0004
837 PERICARDITIS 7 0.0004
838 BLOOD PRESSURE FLUCTUATION 10 0.0004
839 POST PROCEDURAL COMPLICATION 8 0.0004
840 BACK PAIN 96 0.0004
841 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
842 HYPERHIDROSIS 53 0.0004
843 DYSPNOEA 232 0.0004
844 RASH 178 0.0004
845 DISORIENTATION 16 0.0004
846 EYE SWELLING 15 0.0004
847 GASTROINTESTINAL DISORDER 36 0.0004
848 DIARRHOEA 258 0.0004
849 FULL BLOOD COUNT DECREASED 8 0.0004
850 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
851 DRUG ERUPTION 7 0.0004
852 MUSCLE TWITCHING 9 0.0004
853 RENAL DISORDER 18 0.0004
854 TREMOR 64 0.0004
855 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
856 PSYCHOTIC DISORDER 11 0.0004
857 HEART RATE DECREASED 13 0.0004
858 UNDERDOSE 27 0.0004
859 RENAL IMPAIRMENT 31 0.0004
860 BLOOD CHOLESTEROL INCREASED 17 0.0004
861 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
862 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
863 BLINDNESS UNILATERAL 5 0.0004
864 DYSURIA 13 0.0004
865 SOMNOLENCE 71 0.0004
866 RED BLOOD CELL COUNT DECREASED 10 0.0003
867 ABDOMINAL PAIN UPPER 72 0.0003
868 LOSS OF CONSCIOUSNESS 44 0.0003
869 DYSSTASIA 10 0.0003
870 URINARY INCONTINENCE 10 0.0003
871 OESOPHAGEAL CARCINOMA 10 0.0003
872 COMA 16 0.0003
873 THERAPY CESSATION 17 0.0003
874 CEREBROVASCULAR ACCIDENT 56 0.0003
875 ABNORMAL BEHAVIOUR 13 0.0003
876 ABDOMINAL PAIN LOWER 8 0.0003
877 THERAPEUTIC RESPONSE DECREASED 19 0.0003
878 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
879 MENORRHAGIA 6 0.0003
880 LABORATORY TEST ABNORMAL 9 0.0003
881 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
882 SWELLING 28 0.0003
883 LACRIMATION INCREASED 9 0.0003
884 DERMATITIS 6 0.0003
885 COLD SWEAT 5 0.0003
886 NEPHROLITHIASIS 13 0.0003
887 LYMPHADENOPATHY 10 0.0003
888 FLUID RETENTION 14 0.0003
889 RASH GENERALISED 7 0.0003
890 CONTUSION 26 0.0003
891 NECK PAIN 15 0.0003
892 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
893 FLATULENCE 15 0.0003
894 BLOOD URINE PRESENT 5 0.0003
895 WEIGHT DECREASED 73 0.0003
896 SKIN DISCOLOURATION 12 0.0003
897 FEELING HOT 16 0.0003
898 DRUG ADMINISTRATION ERROR 8 0.0003
899 PARAESTHESIA 41 0.0003
900 RASH PRURITIC 14 0.0003
901 DEATH 215 0.0002
902 MOVEMENT DISORDER 8 0.0002
903 DRUG INTOLERANCE 24 0.0002
904 GAIT DISTURBANCE 46 0.0002
905 PRURITUS 92 0.0002
906 NASAL CONGESTION 14 0.0002
907 RENAL FAILURE ACUTE 10 0.0002
908 COGNITIVE DISORDER 11 0.0002
909 BLOOD GLUCOSE INCREASED 44 0.0002
910 PRODUCTIVE COUGH 11 0.0002
911 MALAISE 101 0.0002
912 FALL 76 0.0002
913 THERAPY INTERRUPTED 16 0.0002
914 TREATMENT FAILURE 18 0.0002
915 RHABDOMYOLYSIS 9 0.0002
916 HYPOAESTHESIA 32 0.0002
917 PRODUCT USE ISSUE 40 0.0002
918 OCULAR HYPERAEMIA 10 0.0002
919 SPEECH DISORDER 11 0.0002
920 BLOOD GLUCOSE DECREASED 10 0.0002
921 INFLUENZA 23 0.0002
922 URINARY TRACT INFECTION 35 0.0002
923 ACUTE MYOCARDIAL INFARCTION 6 0.0002
924 ABASIA 5 0.0002
925 CONDITION AGGRAVATED 61 0.0002
926 DIZZINESS 100 0.0002
927 BLOOD PRESSURE INCREASED 30 0.0002
928 EYE PAIN 11 0.0002
929 EMOTIONAL DISORDER 6 0.0002
930 MYALGIA 33 0.0002
931 FATIGUE 151 0.0002
932 DIPLOPIA 5 0.0002
933 SWOLLEN TONGUE 6 0.0002
934 PAIN 114 0.0002
935 MENTAL DISORDER 8 0.0002
936 TREATMENT NONCOMPLIANCE 10 0.0002
937 VISUAL ACUITY REDUCED 6 0.0002
938 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
939 ANXIETY 50 0.0002
940 TINNITUS 8 0.0002
941 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
942 MUSCULOSKELETAL PAIN 9 0.0002
943 RASH MACULAR 6 0.0002
944 MUSCULOSKELETAL STIFFNESS 15 0.0002
945 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
946 ARRHYTHMIA 8 0.0002
947 VISION BLURRED 23 0.0002
948 DISCOMFORT 10 0.0002
949 ADVERSE EVENT 15 0.0002
950 WEIGHT INCREASED 36 0.0002
951 DRUG INEFFECTIVE 210 0.0002
952 INTESTINAL OBSTRUCTION 6 0.0002
953 MOBILITY DECREASED 11 0.0002
954 BRONCHITIS 11 0.0001
955 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
956 PERIPHERAL SWELLING 22 0.0001
957 SUICIDAL IDEATION 13 0.0001
958 EMOTIONAL DISTRESS 17 0.0001
959 ARTHRALGIA 58 0.0001
960 VAGINAL HAEMORRHAGE 6 0.0001
961 DRUG EFFECT INCOMPLETE 5 0.0001
962 ABDOMINAL DISCOMFORT 22 0.0001
963 BLISTER 7 0.0001
964 BLINDNESS 5 0.0001
965 DYSPHONIA 7 0.0001
966 UNEVALUABLE EVENT 9 0.0001
967 VISUAL IMPAIRMENT 14 0.0001
968 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
969 PALPITATIONS 13 0.0001
970 AGGRESSION 5 0.0001
971 DISTURBANCE IN ATTENTION 5 0.0001
972 BALANCE DISORDER 8 0.0001
973 ADVERSE DRUG REACTION 8 0.0001
974 DEPRESSION 20 0.0001
975 INSOMNIA 23 0.0001
976 SLEEP DISORDER 6 0.0001
977 ATRIAL FIBRILLATION 8 0.0001
978 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
979 HALLUCINATION 6 0.0001
980 CHRONIC KIDNEY DISEASE 6 0.0001
981 ALOPECIA 15 0.0001
982 FEELING ABNORMAL 18 0.0001
983 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
984 MEMORY IMPAIRMENT 10 0.0001
985 SKIN EXFOLIATION 6 0.0001
986 HOSPITALISATION 9 0.0001
987 ILLNESS 6 0.0001
988 OVERDOSE 12 0.0001
989 NASOPHARYNGITIS 10 0.0001
990 PRODUCT QUALITY ISSUE 6 0.0000
991 MUSCLE SPASMS 8 0.0000
992 MYOCARDIAL INFARCTION 7 0.0000
993 NO ADVERSE EVENT 6 0.0000
994 INCORRECT DOSE ADMINISTERED 6 0.0000